Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Topalogu, Haluk
NCT05938023: A Study of ATL1102 or Placebo in Participants with Non-ambulatory Duchenne Muscular Dystrophy	Terminated	2	48	Europe, RoW	ATL1102 25mg, ATL1102 50mg, Placebo	Percheron Therapeutics	Duchenne Muscular Dystrophy	11/24	01/25